The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

Up to 8 in 10 Americans carry a common viral infection that may raise the risk of developing Alzheimer’s disease, new research suggests.

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease. advertisement What to know about Lumipulse.

The first Alzheimer's blood test from Fujirebio Diagnostics, now approved by FDA, could help patients with the disease get treatment faster. Skip to Main Content Manage alerts for this article ...

About 7 million U.S. residents aged 65 and older have Alzheimer’s, the nation’s seventh-leading cause of death. Given the cresting age wave, the number is expected to roughly double in the ...

A survey of 1,700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's disease. Accessibility links. Skip to main content; ...

The FDA's sign-off on marketing for Fujirebio's test comes years after other blood tests for Alzheimer's have already begun sales, without this kind of approval from the agency.

An estimated 6.7 million Americans were living with Alzheimer’s in 2023. Newsletters Games Share a News Tip. Featured. Featured. Breaking News. White House Watch. Daily Cover Stories.

Alzheimer's Association says the nation needs to take charge of their brain health, nothing as many as 45% of dementia cases may be avoided through healthy changes. Skip Navigation.

The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease or related forms of dementia, according to new research.

Bill Gates says he is 'really excited' about the progress recently made in the fight against Alzheimer’s disease and related dementias.